Business Context and Reporting Period
Company: Castellum, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 13, 2023
Reporting Period: Specific event date of February 13, 2023.
Context: The Company entered into a series of transactions with Crom Cortana Fund LLC ("Crom") primarily to fund a pending acquisition and refinance existing debt.
Key Financial Metrics and Transaction Details
This filing details a debt refinancing and equity financing transaction rather than standard periodic financial results. Key metrics include:
- Debt Repayment: Settlement of a $1,050,000 convertible promissory note (2022 Note Payable) originally due April 4, 2023.
- Repayment Terms: $300,000 cash payment plus issuance of 556,250 shares of common stock.
- New Debt Issuance: $840,000 convertible promissory note (2023 Note Payable) maturing February 13, 2024.
- Interest Rate: 10% per annum (monthly payments); 18% default rate.
- Equity Issuance (Warrant): Warrant to purchase up to 700,000 shares at an exercise price of $1.38, expiring in 60 months.
- Conversion Price: New note convertible at $1.20 per share at Crom's option.
- Revenue/Profit/Cash Flow: The filing text does not provide a clear value for revenue, profit, operating cash flow, or liquidity ratios.
Material Changes Versus Prior Period
The filing does not provide comparative financial data (e.g., year-over-year revenue or profit changes). The material change is the restructuring of the Company's capital structure:
- Elimination of the $1,050,000 2022 Note Payable obligation.
- Assumption of a new $840,000 debt obligation with a one-year maturity.
- Issuance of new equity instruments (556,250 shares and 700,000 warrant shares) to Crom.
Guidance, Outlook, and Risks
Management Commentary and Use of Proceeds: Proceeds from the new $840,000 note will be used primarily to fund a pending acquisition and to repay the previous debt obligation. A press release dated February 15, 2023, announced a "$500,000 Equity Financing to Support an Acquisition."
Risks and Contingencies:
- Default Risk: The new note carries an 18% default interest rate.
- Dilution: Potential dilution from the conversion of the new note and exercise of the warrant.
- Acquisition Dependency: The financing is explicitly tied to funding a pending acquisition; failure to close the acquisition could impact the utility of these funds.
Important Facts for Investor Verification
- Verify the status and expected closing date of the "pending acquisition" mentioned as the primary use of proceeds.
- Confirm the total number of shares outstanding post-transaction to assess dilution impact from the 556,250 shares issued and the 700,000 warrant shares.
- Review the Company's cash position to ensure it can meet the monthly interest payments on the new 10% note.
- Check for any subsequent filings regarding the completion of the acquisition or further financing needs.